Portage Signs a Collaborative Research and Development Agreement with U.S. National Institute of Health Press ReleaseBy Portage Biotech, IncMay 15, 2014...
Portage’s Biohaven Issued Notice of Allowance: Glutamate Agents in the Treatment of Mental Disorders Press ReleaseBy Portage Biotech, IncMay 5, 2014...
Portage Reports Third Quarter Financial Results and Provides Updates Press ReleaseBy Portage Biotech, IncFebruary 25, 2014...
Portage Acquires Majority Interest in Biohaven Pharmaceutical Holding Company Limited Press ReleaseBy Portage Biotech, IncJanuary 6, 2014...
Portage Lauches New Website and Provides Update on its R&D Activities Press ReleaseBy Portage Biotech, IncDecember 17, 2013...
Portage Announces Listing on Canadian National Stock Exchange Press ReleaseBy Portage Biotech, IncOctober 25, 2013...
Portage Biotech Inc’s Name Change and New Trading Symbol Approved by FINRA Press ReleaseBy Portage Biotech, IncAugust 22, 2013...
